These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 21930290)

  • 1. Non-viral vectors for the mediation of RNAi.
    Zhang S; Zhao Y; Zhi D; Zhang S
    Bioorg Chem; 2012 Feb; 40(1):10-18. PubMed ID: 21930290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid-based vectors for siRNA delivery.
    Zhang S; Zhi D; Huang L
    J Drug Target; 2012 Nov; 20(9):724-35. PubMed ID: 22994300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cationic lipids and polymers mediated vectors for delivery of siRNA.
    Zhang S; Zhao B; Jiang H; Wang B; Ma B
    J Control Release; 2007 Oct; 123(1):1-10. PubMed ID: 17716771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. siRNA delivery: from lipids to cell-penetrating peptides and their mimics.
    Gooding M; Browne LP; Quinteiro FM; Selwood DL
    Chem Biol Drug Des; 2012 Dec; 80(6):787-809. PubMed ID: 22974319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current status of non-viral vectors for siRNA delivery].
    Yang FF; Huang W; Li YF; Gao ZG
    Yao Xue Xue Bao; 2011 Dec; 46(12):1436-43. PubMed ID: 22375415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-penetrating peptides (CPPs) as a vector for the delivery of siRNAs into cells.
    Nakase I; Tanaka G; Futaki S
    Mol Biosyst; 2013 May; 9(5):855-61. PubMed ID: 23306408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA interference technology with emphasis on delivery vehicles-prospects and limitations.
    Prabha S; Vyas R; Gupta N; Ahmed B; Chandra R; Nimesh S
    Artif Cells Nanomed Biotechnol; 2016 Sep; 44(6):1391-9. PubMed ID: 26140615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conjugates of small targeting molecules to non-viral vectors for the mediation of siRNA.
    Zhi D; Zhao Y; Cui S; Chen H; Zhang S
    Acta Biomater; 2016 May; 36():21-41. PubMed ID: 27045350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid-based nanoparticles in the systemic delivery of siRNA.
    Lin Q; Chen J; Zhang Z; Zheng G
    Nanomedicine (Lond); 2014 Jan; 9(1):105-20. PubMed ID: 24354813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly efficient delivery of siRNA to a heart transplant model by a novel cell penetrating peptide-dsRNA binding domain.
    Li H; Zheng X; Koren V; Vashist YK; Tsui TY
    Int J Pharm; 2014 Jul; 469(1):206-13. PubMed ID: 24768403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent patents in siRNA delivery employing nanoparticles as delivery vectors.
    Nimesh S
    Recent Pat DNA Gene Seq; 2012 Aug; 6(2):91-7. PubMed ID: 22670609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTD/CPP peptide-mediated delivery of siRNAs.
    Presente A; Dowdy SF
    Curr Pharm Des; 2013; 19(16):2943-7. PubMed ID: 23140460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chitosan-based siRNA delivery systems.
    Ragelle H; Vandermeulen G; Préat V
    J Control Release; 2013 Nov; 172(1):207-218. PubMed ID: 23965281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylatable short peptide conjugated low molecular weight chitosan for efficient siRNA delivery and target gene silencing.
    Kong F; Liu G; Sun B; Zhou S; Zuo A; Zhao R; Liang D
    Int J Pharm; 2012 Jan; 422(1-2):445-53. PubMed ID: 22067703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-covalent Encapsulation of siRNA with Cell-Penetrating Peptides.
    Tuttolomondo M; Ditzel HJ
    Methods Mol Biol; 2021; 2282():353-376. PubMed ID: 33928584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bridging small interfering RNA with giant therapeutic outcomes using nanometric liposomes.
    Singh Y; Tomar S; Khan S; Meher JG; Pawar VK; Raval K; Sharma K; Singh PK; Chaurasia M; Surendar Reddy B; Chourasia MK
    J Control Release; 2015 Dec; 220(Pt A):368-387. PubMed ID: 26528900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent developments in nanoparticle-based siRNA delivery for cancer therapy.
    Lee JM; Yoon TJ; Cho YS
    Biomed Res Int; 2013; 2013():782041. PubMed ID: 23844368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Next-Generation Lipids in RNA Interference Therapeutics.
    Rietwyk S; Peer D
    ACS Nano; 2017 Aug; 11(8):7572-7586. PubMed ID: 28727419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation, Characterization, and In Vitro Evaluation of Lipidoid-Polymer Hybrid Nanoparticles for siRNA Delivery to the Cytosol.
    Thanki K; Zeng X; Foged C
    Methods Mol Biol; 2019; 1943():141-152. PubMed ID: 30838614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-Penetrating Peptides Delivering siRNAs: An Overview.
    Falato L; Gestin M; Langel Ü
    Methods Mol Biol; 2021; 2282():329-352. PubMed ID: 33928583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.